RNA lipid nanoparticle engineering stops liver fibrosis in its tracks, reverses damage
Since the success of the COVID-19 vaccine, RNA therapies have been the object of increasing interest in the biotech world. These therapies work with your body to target the genetic root of diseases and infections, a promising ...